A 26 + 26-week, randomized, open, parallel controlled, multicenter clinical study comparing the efficacy and safety of INS068 injection and insulin glargine combined with oral hypoglycemic agents in patients with type 2 diabetes mellitus who were newly treated with insulin
| Title | A 26 + 26-week, randomized, open, parallel controlled, multicenter clinical study comparing the efficacy and safety of INS068 injection and insulin glargine combined with oral hypoglycemic agents in patients with type 2 diabetes mellitus who were newly treated with insulin |
|---|---|
| Description | This project is a randomized, open, parallel controlled, multicenter clinical study aimed at comparing the efficacy and safety of INS068 injection and insulin glargine combined with oral hypoglycemic drugs in patients with type 2 diabetes mellitus newly treated with insulin. It is expected to be submitted to FDA in September for post-phase 2 communication |
| Organism | Homo sapiens |
| Data Type | Clinical Research data |
| Data Accessibility | Controlled-access |
| BioProject | PRJCA011393 |
| Release Date | 2024-08-23 |
| Submitter | miao wang (miao.wang.mw5@hengrui.com) |
| Organization | Jiangsu Hengrui Pharmaceutical Co., Ltd |
| Submission Date | 2022-08-24 |
HTTP download speed may be slow. It is highly recommended that you download the dataset using a dedicated FTP tool (such as FileZilla Client).
| File ID | File Title | Number/Samples | File Type | File Size | File Suffix | Download Times | Download |
|---|---|---|---|---|---|---|---|
| OMIX001665-01 | A clinical study comparing the efficacy and safety of INS068 injection and insulin glargine combined with oral hypoglycemic agents in patients with type 2 diabetes mellitus | 1 | Clinical Research data | 458.6 KB | zip | 0 | Controlled |